Tolterodine once-daily in treatment of the overactive bladder

By Peters K.M.   Huang R.R.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 829-829

Elsevier

Access to resources Recommend Favorite

Tolterodine once-daily in treatment of the overactive bladder: Reply by the author

By Van Kerrebroeck P.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 831-832

Elsevier

Access to resources Recommend Favorite

A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women

By Sand Peter   Miklos John   Ritter Henry   Appell Rodney  

International Urogynecology Journal, Vol. 15, Iss. 4, 2004-08 ,pp. : 243-248

Springer Publishing Company

Access to resources Recommend Favorite

A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden

By Peeker Ralph   Samsioe Gööran   Kowalski Jan   Andersson Ann-Sofie   Bergqvist Agneta  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 3, 2010-04 ,pp. : 138-146

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Safety, Tolerability and Efficacy of Extended-Release Tolterodine in the Treatment of Overactive Bladder

By Kreder K.   Mayne C.   Jonas U.  

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 588-595

Elsevier

Access to resources Recommend Favorite